204 related articles for article (PubMed ID: 28235967)
1. Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study.
Nagane Y; Murai H; Imai T; Yamamoto D; Tsuda E; Minami N; Suzuki Y; Kanai T; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Aoki M; Utsugisawa K
BMJ Open; 2017 Feb; 7(2):e013278. PubMed ID: 28235967
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality-of-life and treatment targets in myasthenia gravis.
Utsugisawa K; Suzuki S; Nagane Y; Masuda M; Murai H; Imai T; Tsuda E; Konno S; Nakane S; Suzuki Y; Fujihara K; Suzuki N
Muscle Nerve; 2014 Oct; 50(4):493-500. PubMed ID: 24536040
[TBL] [Abstract][Full Text] [Related]
3. Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan.
Imai T; Utsugisawa K; Murai H; Tsuda E; Nagane Y; Suzuki Y; Minami N; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Akaishi T; Aoki M
J Neurol Neurosurg Psychiatry; 2018 May; 89(5):513-517. PubMed ID: 29175893
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between oral corticosteroid therapy and present disease status in myasthenia gravis].
Imai T
Rinsho Shinkeigaku; 2013; 53(11):1306-8. PubMed ID: 24291969
[TBL] [Abstract][Full Text] [Related]
5. Fatigue, self-efficacy and psychiatric symptoms influence the quality of life in patients with myasthenia gravis in Tianjin, China.
Fan X; Xing C; Yang L; Wang J; Feng L
J Clin Neurosci; 2020 Sep; 79():84-89. PubMed ID: 33070925
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in 188 patients with myasthenia gravis in China.
Yang Y; Zhang M; Guo J; Ma S; Fan L; Wang X; Li C; Guo P; Wang J; Li H; Li Z
Int J Neurosci; 2016; 126(5):455-62. PubMed ID: 26000922
[TBL] [Abstract][Full Text] [Related]
7. Oral corticosteroid therapy and present disease status in myasthenia gravis.
Imai T; Suzuki S; Tsuda E; Nagane Y; Murai H; Masuda M; Konno S; Suzuki Y; Nakane S; Fujihara K; Suzuki N; Utsugisawa K
Muscle Nerve; 2015 May; 51(5):692-6. PubMed ID: 25155615
[TBL] [Abstract][Full Text] [Related]
8. Determinants of quality of life in Brazilian patients with myasthenia gravis.
Mourão AM; Gomez RS; Barbosa LS; Freitas Dda S; Comini-Frota ER; Kummer A; Lemos SM; Teixeira AL
Clinics (Sao Paulo); 2016 Jul; 71(7):370-4. PubMed ID: 27464292
[TBL] [Abstract][Full Text] [Related]
9. [Clinical factors affecting quality of life and treatment targets in patients with myasthenia gravis].
Nagane Y
Rinsho Shinkeigaku; 2013; 53(11):1299-302. PubMed ID: 24291967
[TBL] [Abstract][Full Text] [Related]
10. Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis.
Braz NFT; Rocha NP; Vieira ÉLM; Barbosa IG; Gomez RS; Kakehasi AM; Teixeira AL
J Clin Neurosci; 2018 Apr; 50():41-44. PubMed ID: 29396072
[TBL] [Abstract][Full Text] [Related]
11. [Investigation and analysis of health-related quality of life in myasthenia gravis patients with myasthenia gravis quality of life-15 Chinese version].
Miao XH; Lian ZY; Liu J; Chen HX; Shi ZY; Zhou HY; Yang R
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):514-520. PubMed ID: 29930422
[TBL] [Abstract][Full Text] [Related]
12. Response to treatment of myasthenia gravis according to clinical subtype.
Akaishi T; Suzuki Y; Imai T; Tsuda E; Minami N; Nagane Y; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Murai H; Aoki M; Utsugisawa K
BMC Neurol; 2016 Nov; 16(1):225. PubMed ID: 27855632
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life of Myasthenia Gravis Patients in Regard to Epidemiological and Clinical Characteristics of the Disease.
Stojanov A; Milošević V; Đorđević G; Stojanov J
Neurologist; 2019 Jul; 24(4):115-120. PubMed ID: 31246720
[TBL] [Abstract][Full Text] [Related]
14. The MG-QOL15 Japanese version: validation and associations with clinical factors.
Masuda M; Utsugisawa K; Suzuki S; Nagane Y; Kabasawa C; Suzuki Y; Shimizu Y; Utsumi H; Fujihara K; Uchiyama S; Suzuki N
Muscle Nerve; 2012 Aug; 46(2):166-73. PubMed ID: 22806364
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in purely ocular myasthenia in Japan.
Suzuki S; Murai H; Imai T; Nagane Y; Masuda M; Tsuda E; Konno S; Oji S; Nakane S; Motomura M; Suzuki N; Utsugisawa K
BMC Neurol; 2014 Jul; 14():142. PubMed ID: 24996227
[TBL] [Abstract][Full Text] [Related]
16. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
[TBL] [Abstract][Full Text] [Related]
17. Duration of unemployment and depression: a cross-sectional survey in Lithuania.
Stankunas M; Kalediene R; Starkuviene S; Kapustinskiene V
BMC Public Health; 2006 Jul; 6():174. PubMed ID: 16822310
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Associated Factors of Depressive Symptoms in Patients with Myasthenia Gravis: A Cross-Sectional Study of Two Tertiary Hospitals in Riyadh, Saudi Arabia.
Alanazy MH
Behav Neurol; 2019; 2019():9367453. PubMed ID: 31636730
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study.
Suzuki Y; Utsugisawa K; Suzuki S; Nagane Y; Masuda M; Kabasawa C; Shimizu Y; Utsumi H; Uchiyama S; Fujihara K; Suzuki N
BMJ Open; 2011; 1(2):e000313. PubMed ID: 22184587
[TBL] [Abstract][Full Text] [Related]
20. Fatigue in myasthenia gravis: risk factors and impact on quality of life.
Hoffmann S; Ramm J; Grittner U; Kohler S; Siedler J; Meisel A
Brain Behav; 2016 Oct; 6(10):e00538. PubMed ID: 27781147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
